How Common Are Treatment Breakthroughs?
A new study adds nuance to the ‘golden age’ of cancer drug approvals.
Progress Against Cancer
A new study adds nuance to the ‘golden age’ of cancer drug approvals.
COVID-19 boosters promote immune response in additional blood cancer patients, and high drug costs lead cancer patients to not fill prescriptions.
The FDA approved a kinase inhibitor for the treatment of inflammatory myofibroblastic tumors in children and adults. The U.S. Food and Drug Administration has approved crizotinib (Xalkori) for the treatment of certain patients 1...
People in treatment for early-stage cancer should try to get exercise, according to new recommendations.
Accounting for less than 1 percent of all newly diagnosed cancers in the United States each year, sarcomas are relatively rare. However, these cancers lead to death in approximately 35 percent of patients diagnosed...
Motherhood does not decrease chance of survival for women who have had breast cancer, and other stories from the week in cancer news.
Colorectal cancer screening less prevalent in the younger end of the recommended age group, and cancer patients targeted online with ads for unproven treatment.
Screenings, treatment advances and declines in smoking have led to a decrease in lung cancer death rates.
New studies find that electronic cigarettes trail other methods in helping people quit smoking, but they are growing in popularity among teens.
Younger Americans are less likely to get screened for colorectal cancer screening, a study finds. The gaps were largest among racial and ethnic minorities and socioeconomically disadvantaged individuals.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn MoreYour donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now